Minoxidil side effects: A complete guide

DoktorABC editorial team

Accurate, up-to-date health information written by our editorial team and reviewed by UK-registered prescribers.

How common are minoxidil side effects overall?

Both topical and oral minoxidil have well-established safety profiles, with the large majority of users tolerating treatment without serious adverse effects.

Topical minoxidil is generally well tolerated. The most common side effects are scalp irritation and increased hair shedding during the initial phase of treatment. 

For oral minoxidil at the low doses used for hair loss, the evidence is similarly reassuring. The most frequent adverse event with low-dose oral minoxidil is hypertrichosis, occurring in approximately 15% of patients, with a higher incidence in women and at higher doses. Fluid retention affects 1.3 to 10% of patients, particularly women, and typically occurs within one to three months of treatment. 

Serious adverse events at the low doses used for hair loss are uncommon but not absent, and the distinction between topical and oral formulations is an important distinction that is highlighted throughout this guide.

Side effects of topical minoxidil

Topical minoxidil is applied directly to the scalp and has minimal systemic absorption at standard doses, which is why its side effect profile is considerably milder than the oral form.

Scalp irritation, dryness, and itching

Scalp irritation is the most commonly reported side effect of topical minoxidil. Scalp irritation is more frequent with the alcohol-based solution due to its propylene glycol content. The 5% foam, which lacks propylene glycol, has been associated with significantly reduced irritation and higher patient adherence. 

If scalp irritation is significant with the solution, switching to the foam formulation often resolves the problem. Persistent or severe irritation warrants a review with your prescriber or pharmacist.

Initial hair shedding

Many people experience increased hair shedding in the first two to eight weeks of using topical minoxidil. This is temporary and is a recognised part of how minoxidil works. It shifts hair follicles from the resting phase into the active growth phase, causing existing resting hairs to shed before new growth begins.

Facial hair growth (hypertrichosis)

The risk of hypertrichosis is influenced by the concentration of topical minoxidil, with individuals treated with 5% minoxidil solution more likely to develop unwanted hair growth. This is more commonly reported in women and is caused by inadvertent spread of the solution from the scalp to the face, particularly the forehead and temples.

Applying minoxidil carefully to the scalp only, washing hands thoroughly after application, and avoiding touching the face immediately after use reduces this risk considerably.

Side effects of oral minoxidil

Oral minoxidil produces a systemic effect, meaning it circulates in the bloodstream rather than acting only at the site of application. This produces a broader side effect profile than the topical form, and explains why medical supervision is essential.

Hypertrichosis (unwanted body hair growth)

Hypertrichosis is the most frequent adverse event with low-dose oral minoxidil, occurring in approximately 15% of patients. This refers to increased hair growth in areas beyond the scalp, including the face, arms, and legs. It is more pronounced in women and at higher doses. For many patients it is manageable; for some it is a reason to discontinue treatment. 

Fluid retention and ankle swelling

Fluid retention affects 1.3 to 10% of patients taking low-dose oral minoxidil, typically occurring within one to three months of treatment. It most commonly presents as mild ankle swelling (peripheral oedema). Patients with pre-existing heart or kidney conditions are at higher risk and require particularly careful monitoring. 

Heart palpitations and cardiovascular effects

Minoxidil originally developed as an antihypertensive and retains vasodilatory properties even at the low doses used for hair loss. Some patients report awareness of their heartbeat or mild palpitations. In a prospective study of patients using low-dose oral minoxidil for hair loss, no significant changes in blood pressure or heart rate were observed. However, this does not mean the risk is absent for all patients, and cardiovascular assessment before prescribing is standard practice. 

Fatigue

Mild fatigue is reported by a subset of patients on oral minoxidil, likely related to the vasodilatory effect and modest blood pressure reduction. It is generally mild and often resolves as the body adjusts.

Minoxidil side effects in men

For men using topical minoxidil at 5%, the side effect profile is as described above, primarily scalp irritation, initial shedding, and the low risk of facial hypertrichosis.

Sexual side effects: what does the evidence show?

Unlike finasteride, which has a well-documented and pharmacologically plausible association with sexual side effects including reduced libido, erectile dysfunction, and ejaculatory disorders, minoxidil does not act on androgen pathways and has no established pharmacological mechanism for causing sexual dysfunction.

The clinical evidence does not support a meaningful causal link between minoxidil (topical or low-dose oral) and sexual side effects. Reports exist in post-marketing data, but these are low in frequency and do not demonstrate causation. Men who experience sexual difficulties while taking minoxidil should discuss this with their prescriber to rule out other causes.

Minoxidil side effects in women

Women using topical minoxidil most commonly report scalp irritation, initial shedding, and facial hypertrichosis, as described above. The 2% solution is the most commonly recommended concentration for women, as the 5% solution carries a higher risk of unwanted facial hair growth.

For women taking oral minoxidil, hypertrichosis and fluid retention are reported at higher rates than in men. Hypertrichosis has a higher incidence in women, and fluid retention also occurs more frequently in female patients. Women of childbearing potential should be aware that oral minoxidil is contraindicated in pregnancy, and effective contraception should be used throughout treatment. 

Side effects of minoxidil spray

Minoxidil sprays are a variant of the topical solution, designed for easier application to the scalp. The active ingredient and concentration are the same as the standard solution, and the side effect profile is therefore comparable, including scalp irritation, initial shedding, and the risk of hypertrichosis with inadvertent facial contact.

The spray format does not reduce systemic absorption compared to the standard solution, and it does not carry a different safety profile. Any side effect associated with topical minoxidil solution can also occur with the spray.

What happens to side effects after stopping minoxidil?

Stopping topical minoxidil typically leads to a return of hair loss within three to six months, as the follicle-stimulating effect of the medicine wears off. This is not a side effect of stopping but a return to the underlying condition.

Similarly, for oral minoxidil, stopping generally leads to the resolution of systemic side effects including fluid retention and hypertrichosis over several weeks to months. However, as with topical treatment, hair loss typically returns.

Serious and rare side effects: When to seek medical help

The following side effects are rare but serious and require prompt medical attention.

• Pericardial effusion (fluid around the heart): Rare but serious cardiovascular effects including fluid retention, tachycardia, and pericardial effusion are uncommon but recognised, particularly at doses above 5 mg. Symptoms include chest pain, shortness of breath, and a feeling of pressure in the chest. 
• Severe fluid retention: Significant or rapidly worsening ankle or leg swelling, weight gain, or breathlessness.
• Severe allergic reaction: Swelling of the face, lips, or throat, difficulty breathing, or severe skin reaction.

How to minimise minoxidil side effects

Most minoxidil side effects can be reduced with straightforward adjustments to how and when the medicine is used. The guidance below applies separately to topical and oral formulations, as the practical steps differ considerably between the two. 

Topical minoxidil

• Switch from solution to foam if scalp irritation is significant, as the foam formulation contains no propylene glycol
• Apply carefully to the scalp only and wash hands thoroughly after each application to reduce facial hypertrichosis
• Allow the solution or foam to dry completely before contact with pillows, partners, or other skin surfaces
• Do not exceed the recommended dose; more is not better and increases the risk of systemic absorption

Oral minoxidil

• Start at the lowest effective dose and only increase under prescriber guidance
• Attend all follow-up appointments; blood pressure and cardiovascular monitoring are standard practice
• Report any ankle swelling, palpitations, or breathlessness to your prescriber promptly
• Do not purchase oral minoxidil from unregulated online sources; dosing accuracy and product quality cannot be verified

Final thoughts

Minoxidil has a well-established safety record across both its topical and oral forms. For most people, side effects are mild and manageable, and the benefits of treatment outweigh the risks when it is used correctly and with appropriate oversight.

The most important practical distinction is between the two formulations. Topical minoxidil is available over the counter and has a limited systemic effect; oral minoxidil requires a prescription, medical supervision, and ongoing monitoring.

FAQ

The DoktorABC medical advisory board

Dr. Roland Ruiken

Medical advisor, Norway

Dr. Viktor Simunovic

Medical advisor, Croatia

To the medical advisory board